|
Volumn 123, Issue 3, 2006, Pages 193-194
|
Leishmaniasis research - The challenges ahead
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTILEISHMANIAL AGENT;
ANTIMONY;
LEISHMANIA VACCINE;
MILTEFOSINE;
NEW DRUG;
PAROMOMYCIN;
CLINICAL TRIAL;
DRUG COST;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG MARKETING;
EARLY DIAGNOSIS;
EDITORIAL;
ENDEMIC DISEASE;
ENVIRONMENTAL CHANGE;
HUMAN;
LEISHMANIA;
LEISHMANIASIS;
MEDICAL RESEARCH;
NONHUMAN;
PARASITE INCIDENCE;
PARASITE PREVALENCE;
PARASITE TRANSMISSION;
PATHOGENESIS;
PSYCHODIDAE;
SKIN LEISHMANIASIS;
VISCERAL LEISHMANIASIS;
ANIMALS;
HUMANS;
INDIA;
LEISHMANIASIS;
RESEARCH;
|
EID: 33745207104
PISSN: 09715916
EISSN: 09715916
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (13)
|
References (8)
|